JPMORGAN CHASE & CO - PROTARA THERAPEUTICS INC ownership

PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 34 filers reported holding PROTARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18
-98.2%
11
-96.9%
0.00%
Q2 2022$1,000
-85.7%
352
-68.1%
0.00%
Q4 2021$7,000
-87.5%
1,103
-86.3%
0.00%
Q3 2021$56,000
+2700.0%
8,040
+4442.4%
0.00%
Q2 2021$2,000
-91.7%
177
-88.6%
0.00%
Q1 2021$24,000
-41.5%
1,553
-9.3%
0.00%
Q4 2020$41,000
+57.7%
1,713
+13.1%
0.00%
Q3 2020$26,000
-42.2%
1,515
-1.9%
0.00%
Q2 2020$45,0001,5440.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,692,594$4,496,6321.46%
Privium Fund Management (UK) Ltd 119,730$201,1460.16%
Ikarian Capital, LLC 188,664$315,0690.04%
Orbimed Advisors 772,584$1,290,2150.03%
Boxer Capital, LLC 209,227$349,4090.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,000$106,8800.00%
Baker Brothers Advisors 199,671$333,4510.00%
BOOTHBAY FUND MANAGEMENT, LLC 18,864$31,5030.00%
TWO SIGMA INVESTMENTS, LP 27,345$45,6660.00%
OSAIC HOLDINGS, INC. 100$1670.00%
View complete list of PROTARA THERAPEUTICS INC shareholders